Shared decision-making for biologic treatment of autoimmune disease: influence on adherence, persistence, satisfaction, and health care costs.
about
Physicians' communication of risks from non-steroidal anti-inflammatory drugs and attitude towards providing adverse drug reaction information to patients.Safety, Effectiveness, and Treatment Persistence of Golimumab in Elderly Patients with Rheumatoid Arthritis in Real-World Clinical Practice in Japan.
P2860
Shared decision-making for biologic treatment of autoimmune disease: influence on adherence, persistence, satisfaction, and health care costs.
description
2017 nî lūn-bûn
@nan
2017 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Shared decision-making for bio ...... action, and health care costs.
@ast
Shared decision-making for bio ...... action, and health care costs.
@en
type
label
Shared decision-making for bio ...... action, and health care costs.
@ast
Shared decision-making for bio ...... action, and health care costs.
@en
prefLabel
Shared decision-making for bio ...... action, and health care costs.
@ast
Shared decision-making for bio ...... action, and health care costs.
@en
P2093
P2860
P356
P1476
Shared decision-making for bio ...... action, and health care costs.
@en
P2093
Jennifer H Lofland
John C White
Lorie Ellis
Mike P Ingham
Phaedra T Johnson
Sarah C Rosemas
P2860
P304
P356
10.2147/PPA.S133222
P407
P577
2017-05-18T00:00:00Z